Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
Apply
Radiation De-escalation
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step